221 related articles for article (PubMed ID: 23053510)
1. IL-7 restores lymphocyte functions in septic patients.
Venet F; Foray AP; Villars-Méchin A; Malcus C; Poitevin-Later F; Lepape A; Monneret G
J Immunol; 2012 Nov; 189(10):5073-81. PubMed ID: 23053510
[TBL] [Abstract][Full Text] [Related]
2. IFN-α exerts opposing effects on activation-induced and IL-7-induced proliferation of T cells that may impair homeostatic maintenance of CD4+ T cell numbers in treated HIV infection.
Cha L; de Jong E; French MA; Fernandez S
J Immunol; 2014 Sep; 193(5):2178-86. PubMed ID: 25063872
[TBL] [Abstract][Full Text] [Related]
3. STAT5 is critical to maintain effector CD8+ T cell responses.
Tripathi P; Kurtulus S; Wojciechowski S; Sholl A; Hoebe K; Morris SC; Finkelman FD; Grimes HL; Hildeman DA
J Immunol; 2010 Aug; 185(4):2116-24. PubMed ID: 20644163
[TBL] [Abstract][Full Text] [Related]
4. Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice.
Ruan S; Samuelson DR; Assouline B; Morre M; Shellito JE
Infect Immun; 2016 Jan; 84(1):108-19. PubMed ID: 26483405
[TBL] [Abstract][Full Text] [Related]
5. STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study.
Demaret J; Dupont G; Venet F; Friggeri A; Lepape A; Rimmelé T; Morel J; Monneret G
J Leukoc Biol; 2015 Apr; 97(4):791-6. PubMed ID: 25691382
[TBL] [Abstract][Full Text] [Related]
6. Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.
Albareda MC; Perez-Mazliah D; Natale MA; Castro-Eiro M; Alvarez MG; Viotti R; Bertocchi G; Lococo B; Tarleton RL; Laucella SA
J Immunol; 2015 Apr; 194(8):3883-9. PubMed ID: 25769928
[TBL] [Abstract][Full Text] [Related]
7. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
Faller E; Kakal J; Kumar R; Macpherson P
Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
[TBL] [Abstract][Full Text] [Related]
8. TCR activation mimics CD127
Mouillaux J; Allam C; Gossez M; Uberti T; Delwarde B; Hayman J; Rimmelé T; Textoris J; Monneret G; Peronnet E; Venet F
Crit Care; 2019 Apr; 23(1):131. PubMed ID: 30995946
[TBL] [Abstract][Full Text] [Related]
9. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
Sereti I; Dunham RM; Spritzler J; Aga E; Proschan MA; Medvik K; Battaglia CA; Landay AL; Pahwa S; Fischl MA; Asmuth DM; Tenorio AR; Altman JD; Fox L; Moir S; Malaspina A; Morre M; Buffet R; Silvestri G; Lederman MM;
Blood; 2009 Jun; 113(25):6304-14. PubMed ID: 19380868
[TBL] [Abstract][Full Text] [Related]
10. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.
Vranjkovic A; Crawley AM; Patey A; Angel JB
J Leukoc Biol; 2011 Apr; 89(4):499-506. PubMed ID: 21177484
[TBL] [Abstract][Full Text] [Related]
11. IL-2 receptor gamma chain cytokines differentially regulate human CD8+CD127+ and CD8+CD127- T cell division and susceptibility to apoptosis.
Crawley AM; Katz T; Parato K; Angel JB
Int Immunol; 2009 Jan; 21(1):29-42. PubMed ID: 19011158
[TBL] [Abstract][Full Text] [Related]
12. Functional state of CD4+ and CD8+ T lymphocytes and their role in the slow progression of HIV infection in pediatric patients.
Alfonzo MA; Diaz A; Siciliano L; López MG; Hung A; Garcia JF
J Pediatr (Rio J); 2012; 88(2):161-8. PubMed ID: 22543625
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients.
Venet F; Chung CS; Kherouf H; Geeraert A; Malcus C; Poitevin F; Bohé J; Lepape A; Ayala A; Monneret G
Intensive Care Med; 2009 Apr; 35(4):678-86. PubMed ID: 18946659
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.
Nguyen TP; Bazdar DA; Mudd JC; Lederman MM; Harding CV; Hardy GA; Sieg SF
J Leukoc Biol; 2015 Jun; 97(6):1139-46. PubMed ID: 25784743
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.
Francois B; Jeannet R; Daix T; Walton AH; Shotwell MS; Unsinger J; Monneret G; Rimmelé T; Blood T; Morre M; Gregoire A; Mayo GA; Blood J; Durum SK; Sherwood ER; Hotchkiss RS
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515037
[TBL] [Abstract][Full Text] [Related]
16. A novel virotherapy encoding human interleukin-7 improves
Crausaz M; Monneret G; Conti F; Lukaszewicz AC; Marchand JB; Martin P; Inchauspé G; Venet F
Front Immunol; 2022; 13():939899. PubMed ID: 36045686
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
[TBL] [Abstract][Full Text] [Related]
18. Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer.
Vudattu NK; Magalhaes I; Schmidt M; Seyfert-Margolis V; Maeurer MJ
Int J Cancer; 2007 Oct; 121(7):1512-9. PubMed ID: 17546596
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells.
Crawley AM; Vranjkovic A; Young C; Angel JB
Eur J Immunol; 2010 May; 40(5):1396-407. PubMed ID: 20201040
[TBL] [Abstract][Full Text] [Related]
20. Comparative dose-responses of recombinant human IL-2 and IL-7 on STAT5 phosphorylation in CD4+FOXP3- cells versus regulatory T cells: a whole blood perspective.
Dupont G; Demaret J; Venet F; Malergue F; Malcus C; Poitevin-Later F; Morel J; Monneret G
Cytokine; 2014 Sep; 69(1):146-9. PubMed ID: 24947990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
